Vulnerability · CVE-2025-54659
An Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability [CWE-22] vulnerability in Fortinet FortiSOAR Agent Communication Bridge…
Published Mar 10, 2026 · catalog updated Jun 17, 2026 · fortisoar agent communication bridge
Check if you run it
No confirmed exploitation is on record for CVE-2025-54659. EPSS is 0.48%. Act only if a listed version of fortisoar agent communication bridge is installed.
Gaps on this record
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- High7.5
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.48%
- Remediation
- Advisory link
- Affected products
- cpe fortinet/fortisoar agent communication bridge
An Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability [CWE-22] vulnerability in Fortinet FortiSOAR Agent Communication Bridge 1.1.0, FortiSOAR Agent Communication Bridge 1.0 all versions may allow an unauthenticated attacker to read files accessible to the fortisoar user on a system where the agent is deployed, via sending a crafted request to the agent port.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- cpe fortinet/fortisoar agent communication bridge1.0
- cpe fortinet/fortisoar agent communication bridge1.1
How to fix CVE-2025-54659
Recommended remediation
A patch or advisory reference is linked. Open the original publisher for availability by product version.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2025-54659. EPSS is 0.48%. Act only if a listed version of fortisoar agent communication bridge is installed.
Which versions are affected?
Compare what you have installed with fortinet/fortisoar agent communication bridge 1.0; fortinet/fortisoar agent communication bridge 1.1. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
CWE-22: Path Traversal. EPSS 0.48%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Technology hubs
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Mar 10, 2026 · NIST NVD
Detected
An Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability [CWE-22] vulnerability in Fortinet FortiSOAR Agent Communication Bridge 1.1.0, FortiSOAR Agent Communication Bridge 1.0 all versions may allow an unauthenticated attacker to read files accessible to the fortisoar user on a system where the agent is deployed, via sending a crafted request to the agent po
Jun 17, 2026 · NIST NVD
Updated
An Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability [CWE-22] vulnerability in Fortinet FortiSOAR Agent Communication Bridge 1.1.0, FortiSOAR Agent Communication Bridge 1.0 all versions may allow an unauthenticated attacker to read files accessible to the fortisoar user on a system where the agent is deployed, via sending a crafted request to the agent po
Sources
- CVE.orgVulnerability recordCVE-2025-54659
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2025-54659
30-day exploitation probability 0.5%
first.org - NIST NVDVulnerability recordCVE-2025-54659
An Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability [CWE-22] vulnerability in Fortinet FortiSOAR Agent Communication Bridge 1.1.0, FortiSOAR Agent Communication Bridge 1.0 all versions may allow an unauthenticated attacker to read files
nvd.nist.gov
References
Freshness
Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.